Corrigendum: Integrated chemical interpretation and network pharmacology analysis to reveal the anti-liver fibrosis effect of Penthorum chinense

Zenan Du,Doudou Huang,Pengjie Shi,Zhiying Dong,Xiujuan Wang,Mengshuang Li,Wansheng Chen,Feng Zhang,Lianna Sun

DOI: https://doi.org/10.3389/fphar.2022.986072

IF: 5.6

2022-08-10

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.788388.].

pharmacology & pharmacy

What problem does this paper attempt to address?

Corrigendum: Network pharmacology-based prediction of active compounds in Wenyang Jiedu Huayu formula acting on acute-on-chronic liver failure with experimental support in vitro and in vivo

Dan Tang,Ruo-Yu Wang,Ke-Wei Sun,Yunan Wu,Lin Ding,Yang Mo

DOI: https://doi.org/10.3389/fphar.2022.1105804

IF: 5.6

2022-12-01

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.1003479.].

pharmacology & pharmacy
Corrigendum: Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway

Jinbiao He,Yu Yang,Fan Zhang,Yanjuan Li,Xiaosi Li,Xuemei Pu,Xudong He,Mei Zhang,Xinxing Yang,Qiuman Yu,Yan Qi,Xuefang Li,Jie Yu

DOI: https://doi.org/10.3389/fphar.2023.1172950

IF: 5.6

2023-05-19

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.1007274.].

pharmacology & pharmacy
Corrigendum: Exploring the Mechanism of Total Flavonoids of Drynariae Rhizoma to Improve Large Bone Defects by Network Pharmacology and Experimental Assessment

Weipeng Sun,Minying Li,Lei Xie,Zhexing Mai,Yan Zhang,Lieliang Luo,Zijian Yan,Zige Li,Hang Dong,Feng Huang,Zhen Shen,Ziwei Jiang

DOI: https://doi.org/10.3389/fphar.2021.739503

IF: 5.6

2021-07-23

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.603734.].

pharmacology & pharmacy
Corrigendum: Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis

Bing Yang,Liqing Lu,Dongmei Zhou,Wei Fan,Lucía Barbier-Torres,Justin Steggerda,Heping Yang,Xi Yang

DOI: https://doi.org/10.3389/fendo.2023.1284809

IF: 6.055

2023-09-28

Frontiers in Endocrinology

Abstract:[This corrects the article DOI: 10.3389/fendo.2022.1007944.].

endocrinology & metabolism
Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Xiaohua Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Feng Shi,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2022.03.001

IF: 7.376

2022-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.][This corrects the article DOI: 10.1016/j.gendis.2021.09.001.].
Corrigendum: YKL-40 promotes chemokine expression following drug-induced liver injury via TF-PAR1 pathway in mice

Zhan Jing-Lun,Chai Shuang,Zhao Li-Mei,Liu Xiao-Dong

DOI: https://doi.org/10.3389/fphar.2024.1395496

2024-08-15

Abstract:[This corrects the article DOI: 10.3389/fphar.2023.1205062.].
Corrigendum: Liquid chromatograph-mass spectrometry-based non-targeted metabolomics discovery of potential endogenous biomarkers associated with prostatitis rats to reveal the effects of magnoflorine

Yin Yuan,Fei-Xue Dong,Xu Liu,Hong-Bin Xiao,Zhong-Guang Zhou

DOI: https://doi.org/10.3389/fphar.2022.1034753

IF: 5.6

2022-10-12

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.741378.].

pharmacology & pharmacy
Corrigendum: Role and mechanism of DNA methylation and its inhibitors in hepatic fibrosis

Shi-Yi Lyu,Wang Xiao,Guang-Zu Cui,Cheng Yu,Huan Liu,Min Lyu,Qian-Ya Kuang,En-Hua Xiao,Yong-Heng Luo

DOI: https://doi.org/10.3389/fgene.2023.1265506

IF: 3.7

2023-08-11

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2023.1124330.].

genetics & heredity
Corrigendum: An Ethnobotanical Study of Medicinal Plants in Kinmen

Shyh-Shyun Huang,Chia-Hung Huang,Chien-Yu Ko,Ting-Yang Chen,Yung-Chi Cheng,Jung Chao

DOI: https://doi.org/10.3389/fphar.2022.873011

IF: 5.6

2022-03-09

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.681190.].

pharmacology & pharmacy
Corrigendum to “artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis”

Lanlan Xiao,Xingqi Xu,Kaizhou Huang,Yalei Zhao,Lingjian Zhang,Lanjuan Li

DOI: https://doi.org/10.1155/2021/9875940

2021-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2019/3757149.].
Corrigendum: Improvement of antioxidant activity and active ingredient of Dendrobium officinale via microbial fermentation

Gen Yu,QingFen Xie,WenFeng Su,Shuang Dai,XinYi Deng,QuLiang Gu,Shan Liu,JeonYun Yun,WenHao Xiang,Yang Xiong,GuanDong Yang,Yifei Ren,He Li

DOI: https://doi.org/10.3389/fmicb.2023.1179511

IF: 5.2

2023-03-16

Frontiers in Microbiology

Abstract:[This corrects the article DOI: 10.3389/fmicb.2023.1061970.].

microbiology
Corrigendum: Revealing the mechanism of Huazhi Rougan granule in the treatment of nonalcoholic fatty liver through intestinal flora based on 16S rRNA, metagenomic sequencing and network pharmacology

Yingying Liu,Yingying Tan,Jiaqi Huang,Chao Wu,Xiaotian Fan,Antony Stalin,Shan Lu,Haojia Wang,Jingyuan Zhang,Fanqin Zhang,Zhishan Wu,Bing Li,Zhihong Huang,Meilin Chen,Guoliang Cheng,Yanfang Mou,Jiarui Wu

DOI: https://doi.org/10.3389/fphar.2023.1243304

IF: 5.6

2023-07-27

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.875700.].

pharmacology & pharmacy
Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism

Jie Wen,Abudureyimujiang Aili,Yao Xue Yan,YuLin Lai,Shaoqing Niu,Shasha He,Xiaokai Zhang,Guixiong Zhang,Jiaping Li

DOI: https://doi.org/10.3389/fonc.2022.1038279

IF: 4.7

2022-10-26

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.977348.].

oncology
Correction to "Integrated Network Pharmacology Analysis and Serum Metabolomics to Reveal the Antimalaria Mechanism of Artesunate"

Feiran Wang,Jian Song,Yingying Yan,Qian Zhou,Xiaojing Li,Ping Wang,Zongtong Yang,Qiuhong Zhang,Huimin Zhang

DOI: https://doi.org/10.1021/acsomega.2c05623

IF: 4.1

2022-09-29

ACS Omega

Abstract:[This corrects the article DOI: 10.1021/acsomega.2c04157.].
Corrigendum to “ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy”

Song Miao,Jie Lü,Weiqi Dai,Wei Fan,Ling Xu,Kan Chen,Lei He,Ping Cheng,Yan Zhang,Chengfen Wang,Dong Wu,Jing Yang,Rong Zhu,Huawei Zhang,Yingqun Zhou,Chuanyong Guo

DOI: https://doi.org/10.1155/2016/5434275

2016-01-01

Mediators of Inflammation

Abstract:[This corrects the article DOI: 10.1155/2013/461536.].
Corrigendum: Material basis and molecular mechanisms of Chaihuang Qingyi Huoxue Granule in the treatment of acute pancreatitis based on network pharmacology and molecular docking-based strategy

Jia Yang,Yu-Hong Jiang,Xin Zhou,Jia-Qi Yao,Yang-Yang Wang,Jian-Qin Liu,Peng-Cheng Zhang,Wen-Fu Tang,Zhi Li

DOI: https://doi.org/10.3389/fimmu.2024.1429862

2024-06-24

Abstract:[This corrects the article DOI: 10.3389/fimmu.2024.1353695.].
Corrigendum: ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway

Yu-Li Shen,Yi-ping Jiang,Xiao-Qin Li,Su-Juan Wang,Ming-Hua Ma,Chun-Yan Zhang,Jian-Yong Zhu,Khalid Rahman,Li-Jun Zhang,Xin Luan,Hong Zhang

DOI: https://doi.org/10.3389/fphar.2021.789192

IF: 5.6

2021-11-18

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2019.01596.].

pharmacology & pharmacy
Corrigendum: Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review

Zhi-Hua Yang,Bin Wang,Qian Ma,Lin Wang,Ya-Xin Lin,Hai-Feng Yan,Zi-Xuan Fan,Hao-Jia Chen,Zhao Ge,Feng Zhu,Hui-Jie Wang,Bao-Nan Zhang,Hai-Dong Sun,Li-Min Feng

DOI: https://doi.org/10.3389/fphar.2021.770125

IF: 5.6

2021-10-25

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.668407.].

pharmacology & pharmacy
Corrigendum: The Extract of Sonneratia apetala Leaves and Branches Ameliorates Hyperuricemia in Mice by Regulating Renal Uric Acid Transporters and Suppressing the Activation of the JAK/STAT Signaling Pathway

Yu-Lin Wu,Jin-Fen Chen,Lin-Yun Jiang,Xiao-Li Wu,Yu-Hong Liu,Chang-Jun Gao,Yan Wu,Xiao-Qing Yi,Zi-Ren Su,Jian Cai,Jian-Nan Chen

DOI: https://doi.org/10.3389/fphar.2021.760098

IF: 5.6

2021-10-15

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.698219.].

pharmacology & pharmacy
Corrigendum: Network pharmacology and experimental study of phenolic acids in salvia miltiorrhiza bung in preventing ischemic stroke

Chengdi Liu,Lida Du,Sen Zhang,Haigang Wang,Linglei Kong,Guanhua Du

DOI: https://doi.org/10.3389/fphar.2023.1155574

IF: 5.6

2023-02-13

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2023.1108518.].

pharmacology & pharmacy

Corrigendum: Integrated chemical interpretation and network pharmacology analysis to reveal the anti-liver fibrosis effect of Penthorum chinense

Corrigendum: Network pharmacology-based prediction of active compounds in Wenyang Jiedu Huayu formula acting on acute-on-chronic liver failure with experimental support in vitro and in vivo

Corrigendum: Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway

Corrigendum: Exploring the Mechanism of Total Flavonoids of Drynariae Rhizoma to Improve Large Bone Defects by Network Pharmacology and Experimental Assessment

Corrigendum: Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes &amp; Diseases 9(2022) 443–455]

Corrigendum: YKL-40 promotes chemokine expression following drug-induced liver injury via TF-PAR1 pathway in mice

Corrigendum: Liquid chromatograph-mass spectrometry-based non-targeted metabolomics discovery of potential endogenous biomarkers associated with prostatitis rats to reveal the effects of magnoflorine

Corrigendum: Role and mechanism of DNA methylation and its inhibitors in hepatic fibrosis

Corrigendum: An Ethnobotanical Study of Medicinal Plants in Kinmen

Corrigendum to “artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis”

Corrigendum: Improvement of antioxidant activity and active ingredient of Dendrobium officinale via microbial fermentation

Corrigendum: Revealing the mechanism of Huazhi Rougan granule in the treatment of nonalcoholic fatty liver through intestinal flora based on 16S rRNA, metagenomic sequencing and network pharmacology

Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis via regulating the arachidonic acid metabolism

Correction to "Integrated Network Pharmacology Analysis and Serum Metabolomics to Reveal the Antimalaria Mechanism of Artesunate"

Corrigendum to “ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy”

Corrigendum: Material basis and molecular mechanisms of Chaihuang Qingyi Huoxue Granule in the treatment of acute pancreatitis based on network pharmacology and molecular docking-based strategy

Corrigendum: ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway

Corrigendum: Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review

Corrigendum: The Extract of Sonneratia apetala Leaves and Branches Ameliorates Hyperuricemia in Mice by Regulating Renal Uric Acid Transporters and Suppressing the Activation of the JAK/STAT Signaling Pathway

Corrigendum: Network pharmacology and experimental study of phenolic acids in salvia miltiorrhiza bung in preventing ischemic stroke

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]